Recent Updates
Recently added Catalysts
DGX Positive Sentiment

Quest Diagnostics to Release Fourth Quarter and Full Year 2025 Financial Results on February 10, 2026

Key Takeaway: Quest Diagnostics has announced the release date for its fourth quarter and full year 2025 financial results, set for February 10, 2026. The results will be discussed in a conference call at 8:30 a.m. ET on the same day. Participants can access the call via phone or online, with replays available afterward.
Price reaction · baseline $177.74 (2026-01-08 close) · hit pre-market · 1 other DGX headline(s) in the window, move may be shared
day 0 close · peak
-1.9%

Market Sentiment Analysis

POSITIVE FACTORS

  • Quest Diagnostics is a leader in diagnostic information services.
  • The company provides valuable insights that can improve health outcomes.
  • They serve a significant portion of the U.S. population and healthcare providers.

Full Press Release Details

SECAUCUS, N.J.,Jan. 8, 2026/PRNewswire/ -- Quest Diagnostics Incorporated (NYSE: DGX), a leader in diagnostic information services, today announced that it will report fourth quarter and full year 2025 financial results on Tuesday, February 10, 2026, before the market opens. It will hold its quarterly conference call to discuss the results beginning at 8:30 a.m. Eastern Time on that day.
The conference call can be accessed by dialing 888-455-0391 within the U.S. and Canada, or 773-756-0467 internationally, using the passcode: "7895081." The earnings release and live webcast will be posted onwww.QuestDiagnostics.com/investor. The company suggests participants dial in approximately 10 minutes before the call.
A replay of the call may be accessed online atwww.QuestDiagnostics.com/investoror by phone at 866-388-5361 for domestic callers or 203-369-0416 for international callers; no passcode is required. Telephone replays will be available from approximately 10:30 a.m. Eastern Time on February 10, 2026 until midnight Eastern Time on February 24, 2026.
Anyone listening to the call is encouraged to read the company's periodic reports on file with the Securities and Exchange Commission, including the discussion of risk factors and historical results of operations and financial condition in those reports.
About Quest DiagnosticsQuest Diagnostics works across the healthcare ecosystem to create a healthier world, one life at a time. We provide diagnostic insights from the results of our laboratory testing to empower people, physicians and organizations to take action to improve health outcomes. Derived from one of the world's largest databases of de-identifiable clinical lab results, Quest's diagnostic insights reveal new avenues to identify and treat disease, inspire healthy behaviors and improve healthcare management. Quest Diagnostics annually serves one in three adult Americans and half the physicians and hospitals in the United States, and our more than 55,000 employees understand that, in the right hands and with the right context, our diagnostic insights can inspire actions that transform lives and create a healthier world.www.QuestDiagnostics.com.

Frequently Asked Questions

When will Quest Diagnostics release its Q4 2025 results?

Quest Diagnostics will release its fourth quarter and full year 2025 results on February 10, 2026.

What time is the earnings call for Q4 2025 results?

The earnings call will begin at 8:30 a.m. Eastern Time on February 10, 2026.

How can I access the earnings call?

The call can be accessed by dialing 888-455-0391 in the U.S. or 773-756-0467 internationally.

Will there be a replay of the earnings call?

Yes, a replay will be available online and by phone from February 10 to February 24, 2026.

Last updated: Jan 9, 2026